Tower Research Capital LLC (Trc) Capricor Therapeutics, Inc. Transaction History
Tower Research Capital LLC (Trc)
- $4.87 Billion
- Q4 2024
A detailed history of Tower Research Capital LLC (Trc) transactions in Capricor Therapeutics, Inc. stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 6,197 shares of CAPR stock, worth $99,833. This represents 0.0% of its overall portfolio holdings.
Number of Shares
6,197
Previous 23,824
73.99%
Holding current value
$99,833
Previous $362,000
76.52%
% of portfolio
0.0%
Previous 0.01%
Shares
16 transactions
Others Institutions Holding CAPR
# of Institutions
133Shares Held
16MCall Options Held
1.73MPut Options Held
1.71M-
Vanguard Group Inc Valley Forge, PA2.28MShares$36.7 Million0.0% of portfolio
-
Farallon Capital Management LLC San Francisco, CA2.25MShares$36.3 Million0.17% of portfolio
-
State Street Corp Boston, MA2.21MShares$35.6 Million0.0% of portfolio
-
Black Rock Inc. New York, NY1.63MShares$26.2 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA879KShares$14.2 Million0.0% of portfolio
About CAPRICOR THERAPEUTICS, INC.
- Ticker CAPR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 24,346,200
- Market Cap $392M
- Description
- Capricor Therapeutics, Inc., a clinical-stage biotechnology company, focuses on the development of transformative cell and exosome-based therapeutics for the treatment and prevention of spectrum of diseases and disorders. Its lead candidate, CAP-1002, an allogeneic cardiac-derived cell therapy, which has completed phase III clinical trial for th...